Looks like we have run out of cash.Next quarter estimated cash flow 700k cash on hand 516K.Gone from 4182000 to 516K in last 6 months, looking for fund mangers to stoke up cash to get the production running.Thoughts?
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling